Pinnacle Spine Group Receives a Fourth Patent for Graft Device

Pinnacle Spine Group received a U.S. patent for its in situ graft delivery technology, the company announced.

The patent applies to the company’s system for delivery of graft material to the chamber of a spinal fusion device. The company has previously received three patents covering the same fusion technology and owns several non-U.S. applications, including in Europe, Australia and Canada.

The devices hinge on targeted in situ placement of bone graft material directly into the implanted device for maximum contact with the vertebral endplates.